Tirzepatide, a recently approved medication, is sparking considerable excitement within the healthcare community. It operates differently from existing diabetes treatments , targeting both receptors involved in sugar regulation and satiety. Initial studies have demonstrated significant efficacy in lowering blood levels in individuals with type 2 di